title: Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease.
authors: Filippo
authors: F
authors: Mocciaro
authors: Ambrogio
authors: A
authors: Orlando
authors: Sara
authors: S
authors: Renna
authors: Maria Rosa
authors: MR
authors: Rizzuto
authors: Mario
authors: M
authors: Cottone
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068582:Certolizumab Pegol; D003424:Crohn Disease / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects* / Q000627:therapeutic use; D017676:Lichen Planus, Oral / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D061067:Antibodies, Monoclonal, Humanized; D007140:Immunoglobulin Fab Fragments; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol